documents: FDA-2024-D-2033-0002
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2024-D-2033-0002 | FDA | FDA-2024-D-2033 | Expedited Program for Serious Conditions—Accelerated Approval of Drugs and Biologics; Draft Guidance for Industry | Other | Guidance | 2024-12-06T05:00:00Z | 2024 | 12 | 2024-12-06T05:00:00Z | 2025-03-07T04:59:59Z | 2025-07-16T09:00:27Z | 1 | 0 | 090000648684bb37 |
Links from other tables
- 0 rows from regs_document_id in fr_regs_crossref